COMMUNIQUÉS West-GlobeNewswire

Stereotaxis Reports 2023 Full Year Financial Results
04/03/2024
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth [...]
Health Catalyst to Participate in Upcoming Investor Conferences
04/03/2024
SALT LAKE CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced [...]
Apogee to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases on March 5, 2024
04/03/2024
SAN FRANCISCO and WALTHAM, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc . (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic [...]
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
04/03/2024
–Announced prioritization of clinical programs to focus on late-stage development of oral difelikefalin for notalgia paresthetica (NP)– –Completed enrollment of KOURAGE 1 Part A portion of NP pivotal program ahead of [...]
Cytokinetics to Participate in March Investor Conferences
04/03/2024
SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor conferences in March: [...]
Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
04/03/2024
WESTLAKE VILLAGE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Avadel Pharmaceuticals Issues Statement On Patent Litigation
04/03/2024
DUBLIN, Ireland, March 04, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), today issued a statement in response to a jury ruling from the United States District Court for the District of Delaware (“ [...]
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to April 3, 2024
04/03/2024
MIAMI, March 04, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”), a special purpose acquisition company, announced today that on March 1, 2024, its sponsor, [...]
Better Choice to Explore Non-Equity Related Capital Solutions to Fund the R&D of its Domestic Animal Targeted GLP1 Supplement
04/03/2024
NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that after successfully completing the acquisition [...]
Sporttrade and Birches Health Partner to Launch Responsible Gaming Education and Problem Gambling Resources
04/03/2024
ATLANTIC CITY, N.J., March 04, 2024 (GLOBE NEWSWIRE) -- Birches Health and Sporttrade are pleased to kick off Problem Gambling Awareness month (March) by announcing a partnership. This initiative focuses on increasing [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
04/03/2024
Company Announcement COPENHAGEN, Denmark; March 4, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
MannKind Corporation Announces Participation at Upcoming Conferences
04/03/2024
WESTLAKE VILLAGE, Calif. and DANBURY, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products and [...]
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas
04/03/2024
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital [...]
InnovAge Launches First PACE Center in Florida Providing Comprehensive Healthcare Program for Seniors to Promote Independence
04/03/2024
TAMPA, Fla., March 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All- [...]
Resolutions from the Extraordinary Shareholders’ Meeting 2024
04/03/2024
Company Announcement no. 10 March 4, 2024 Today an extraordinary shareholders’ meeting was conducted. The following resolutions were made : Adoption of Novonesis A/S as secondary name and amendment of the Articles of [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
04/03/2024
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following [...]
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024
04/03/2024
Researchers present abstracts and poster sessions showcasing research and clinical solutions Joint session planned with Illumina HOUSTON, March 04, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic [...]
ACTG Presents Study at CROI Elucidating Mechanism of CMV on Aging-Related Pathways in HIV
04/03/2024
LOS ANGELES, March 04, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented the poster “Suppressing Asymptomatic CMV with Letermovir Reshapes [...]
Vaxil Bio Proposed Reverse Takeover with Copper Bullet Terminated and Update of Research Activities
04/03/2024
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, March 04, [...]

Pages